Dyax

 

Advancing Novel Biotherapeutics Since 1995®

Press Releases


2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008
All Releases
View Summary Dyax Corp. to Participate in the 25th Annual Oppenheimer Healthcare Conference
Dec 3, 2014
PDF 22.4 KB Add to Briefcase
View Summary Dyax Corp. Recognized as a "Top Place to Work" by The Boston Globe
Nov 18, 2014
PDF 21.0 KB Add to Briefcase
View Summary Dyax Corp. Announces Expansion of Phase 1b Clinical Trial for DX-2930
Nov 3, 2014
PDF 22.2 KB Add to Briefcase
View Summary Dyax Corp. Announces Third Quarter 2014 Financial Results
Oct 28, 2014
PDF 32.5 KB Add to Briefcase
View Summary Dyax Corp. to Host Third Quarter 2014 Earnings Call and Webcast
Oct 14, 2014
PDF 17.2 KB Add to Briefcase
View Summary Dyax Corp. to Participate in the Leerink Partners Rare Disease Roundtable
Sep 25, 2014
PDF 20.4 KB Add to Briefcase
View Summary Dyax Corp. Highlights Recent Progress in Licensing and Funded Research Portfolio
Sep 22, 2014
PDF 23.9 KB Add to Briefcase
View Summary Dyax Corp. Announces Issuance of Two Key U.S. Patents for DX-2930
Sep 15, 2014
PDF 21.3 KB Add to Briefcase
View Summary Dyax Corp. Announces Second Quarter 2014 Financial Results
Jul 29, 2014
PDF 33.1 KB Add to Briefcase
View Summary Dyax Corp. Announces Publication of Scientific Data for DX-2930 in Peer-Reviewed Journals
Jul 23, 2014
PDF 22.8 KB Add to Briefcase
View Summary Dyax Corp. to Host Second Quarter 2014 Earnings Call and Webcast
Jul 15, 2014
PDF 17.1 KB Add to Briefcase
View Summary Dyax Corp. to Participate in the 2014 Wells Fargo Healthcare Conference
Jun 10, 2014
PDF 20.3 KB Add to Briefcase
View Summary Dyax Corp. to Participate in the Jefferies Global Healthcare Conference
May 29, 2014
PDF 20.5 KB Add to Briefcase
View Summary Dyax Corp. Announces Dosing of First Subject in Phase 1b Trial of DX-2930 in Patients with Hereditary Angioedema
May 28, 2014
PDF 21.8 KB Add to Briefcase
View Summary Dyax Corp. to Participate in the Deutsche Bank 39th Annual Health Care Conference
May 1, 2014
PDF 20.3 KB Add to Briefcase
View Summary Dyax Corp. Announces First Quarter 2014 Financial Results
Apr 30, 2014
PDF 30.9 KB Add to Briefcase
View Summary Dyax Corp. to Host First Quarter 2014 Earnings Call and Webcast
Apr 17, 2014
PDF 17.1 KB Add to Briefcase
View Summary Dyax Corp. Announces Appointment of Todd Bazemore as Chief Commercial Officer
Apr 16, 2014
PDF 20.3 KB Add to Briefcase
View Summary Dyax Receives FDA Approval to Expand Use of KALBITOR® (ecallantide) for the Treatment of Acute Attacks of Hereditary Angioedema to Patients 12 Years of Age and Older
Apr 3, 2014
PDF 21.2 KB Add to Briefcase
View Summary Dyax Corp. to Participate in the 13th Annual Needham Healthcare Conference
Apr 2, 2014
PDF 20.9 KB Add to Briefcase
Showing 1-20 of 207 Page: 1 2 3 4 5 ... 11  Next 20
Add to Briefcase = add release to Briefcase
 

You are now leaving Dyax.com.

The web site you are about to visit is . It is neither owned nor controlled by Dyax Corp. Dyax is not responsible for the content, products or services on this site.

Do you wish to continue?